VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NAGENiagen Bioscience Inc
$3.42$272M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNAGEPrice History

NAGE logoNiagen Bioscience Inc (NAGE) Stock Price History

Historical prices from 2008 to 2026

$3.42+0.11  (+3.32%)close Jun 26
Returns
1M
-11.4%
3M
-23.5%
YTD
-45.3%
1Y
-75.3%
3Y
+29.4%
5Y
-18.8%
ATH$23.66Feb 2021-85.5%
ATL$0.33Aug 2009pre-split
Avg Vol (50D)799K/ day
52-Week Range$3.29 — $14.69
LowCurrent: $3.42High

Loading 10-year price history...

NAGE Historical Performance

1 YearTotal Return
-75.6%
Price: -75.3%
3 YearsTotal Return
+118.4%
CAGR: +29.7%
Price: +116.5%
5 YearsTotal Return
-62.3%
CAGR: -17.7%
Price: -64.7%
YTD
-45.3%

NAGE Annual Returns

Year-by-year price performance · 2008–2026

Best+271.3%2024
Worst-70.0%2008
Up years8/19
2008-70.0%
2009-62.4%
2010+202.2%
2011-59.6%
2012-11.7%
2013+181.5%
2014-37.6%
2015+35.6%
2016-9.6%
2017+70.4%
2018-46.0%
2019+26.4%
2020+11.6%
2021-21.3%
2022-57.1%
2023-15.4%
2024+271.3%
2025+16.1%
2026-19.2%
2008 annual price return
-70.0%
2009 annual price return
-62.4%
2010 annual price return
+202.2%
2011 annual price return
-59.6%
2012 annual price return
-11.7%
2013 annual price return
+181.5%
2014 annual price return
-37.6%
2015 annual price return
+35.6%
2016 annual price return
-9.6%
2017 annual price return
+70.4%
2018 annual price return
-46.0%
2019 annual price return
+26.4%
2020 annual price return
+11.6%
2021 annual price return
-21.3%
2022 annual price return
-57.1%
2023 annual price return
-15.4%
2024 annual price return
+271.3%
2025 annual price return
+16.1%
2026 annual price return
-19.2%
LessMore
Alpha vs S&P 500
1Y-96.4%
3Y+7.9%
5Y-29.2%

Price returns only.

Download Historical Data

4,530 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NAGE Stock Price Trajectory (2008–2026)

As of June 28, 2026, Niagen Bioscience Inc (NAGE) trades at $3.42, representing a -75.3% return over the past year. The stock has delivered a -62.3% total return over five years (-18.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $23.66 on February 25, 2021. From this peak, NAGE has corrected -85.5%, currently trading 41% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers NRXP (+6.6% 1Y), HALO (+42.7% 1Y), and NBIX (+33.0% 1Y), NAGE has underperformed the peer group average. Compare NAGE vs NRXP →

NAGE Historical Price Data · from 2008

Rows 1–50 of 4,530
Date Open High Low Close Volume Change %
2026-06-263.313.433.313.420+3.32%
2026-06-253.463.483.293.31808K-4.06%
2026-06-243.383.563.383.45562K+2.07%
2026-06-233.373.443.373.38258K-0.88%
2026-06-223.513.553.403.41508K-2.57%
2026-06-183.483.533.403.50884K+3.86%
2026-06-173.423.523.353.37481K-1.75%
2026-06-163.523.543.373.43570K-2.56%
2026-06-153.483.583.463.52161K+2.03%
2026-06-123.443.513.433.45467K+0.58%
2026-06-113.483.503.383.43513K-1.15%
2026-06-103.503.583.463.47535K-1.14%
2026-06-093.373.533.373.51772K+4.15%
2026-06-083.613.613.353.37535K-2.32%
2026-06-053.493.573.403.45764K-1.43%
2026-06-043.423.533.423.50573K+1.74%
2026-06-033.503.543.413.44624K-2.82%
2026-06-023.613.623.503.54714K-1.94%
2026-06-013.633.883.603.61960K-6.48%
2026-05-293.833.923.803.861.89M+0.52%
2026-05-283.833.963.833.84700K+0.26%
2026-05-273.884.033.813.831.11M-0.78%
2026-05-263.704.043.693.861.40M+5.46%
2026-05-223.823.833.663.66720K-3.43%
2026-05-213.723.823.693.79913K+1.07%
2026-05-203.663.833.563.75809K+2.18%
2026-05-193.693.793.653.67656K-0.81%
2026-05-183.643.833.643.70798K+1.37%
2026-05-153.743.793.603.651.39M-3.95%
2026-05-143.783.833.713.80812K+1.06%
2026-05-133.813.873.713.761.24M-2.34%
2026-05-123.934.073.763.851.21M-3.27%
2026-05-114.104.223.943.981.95M-4.56%
2026-05-084.234.264.044.171.51M-0.48%
2026-05-074.364.394.044.192.20M-15.69%
2026-05-064.905.074.824.971.18M+3.11%
2026-05-054.935.004.754.82168K-2.23%
2026-05-044.895.124.894.93829K+1.65%
2026-05-014.744.884.714.85404K+2.54%
2026-04-304.754.834.684.73826K-0.63%
2026-04-294.854.894.684.76609K-1.65%
2026-04-284.975.014.824.84573K-2.42%
2026-04-274.955.064.904.96681K+0.61%
2026-04-244.744.964.734.93481K+4.23%
2026-04-235.045.044.714.73767K-5.78%
2026-04-224.815.054.775.02889K+5.91%
2026-04-214.874.954.714.74567K-2.67%
2026-04-204.814.894.794.87406K+0.62%
2026-04-174.844.994.824.84847K+2.33%
2026-04-164.794.854.704.73666K-0.21%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NAGE — Frequently Asked Questions

Quick answers to the most common questions about buying NAGE stock.

How has NAGE stock performed recently?

NAGE declined -75.3% over the past year, below its 5-year annualized CAGR of -18.8%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is NAGE's all-time high price?

Niagen Bioscience Inc reached $23.66 on 2021-02-25. The 52-week high is $14.69. Current 1-year return of -75.3% places the stock further from historical peaks.

Where can I download NAGE historical price data?

This page provides NAGE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2008-2026, downloadable in CSV format.

454 data points · sampled from 4,530